Biocon Limited · NSE:BIOCON

Biocon — Q2 FY2005 Earnings Presentation

7 slides from Biocon's earnings presentation, Oct 20, 2004

  1. Slide 1: Biocon Group Financials H1 FY2005 vs H1 FY2004 Fact Sheet

    BIOCON GROUP FINANCIALS H H11 FFY Y 22000055 vvss H H11 FFY Y 22000044 Q Q22 FFY Y 22000055 vvss Q Q22 FFY Y 22000044 FACT SHEET

  2. Slide 2: Biocon Limited (Consolidated) Profit & Loss Statement

    BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. crores) Variance Variance Full Year Q2 Q2 Q2 FY 05 H1 H1 H1 FY 05 ended Particulars vs vs March 31, FY 2005 FY 2004 Q2 FY 04 FY 2005 FY 2004 H1 FY 04 2004 INCOME Biopharmaceuticals 147 124 19% 287 208 38% 436 Enzymes 24 16 50% 44 32 38% 66 C

  3. Slide 3: Biocon Limited (Consolidated) Balance Sheet

    BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs. crores) Particulars As on As on As on 30-Sep-04 30-Sep-03 31-Mar-04 SOURCES OF FUNDS Share Capital 50 2 50 Reserves & Surplus 620 193 513 Total Shareholder’s Funds 670 195 563 Minority interest 1 0 0 Deferred Tax Liability 19 15 18 Secured Loans 74 48

  4. Slide 4: Biocon Limited (Consolidated) Statement of Cash Flows

    BIOCON LIMITED (CONSOLIDATED) STATEMENT OF CASH FLOWS (Rs. crores) Full Year ended Particulars H1 FY 2005 H1 FY 2004 March 31, 2004 I. Cash Flow from Operating Activities Net profit before tax 112 78 162 Less/Add: non-cash items/ items required separately Depreciation 9 8 16 Others (3) 3 2 Changes i

  5. Slide 5: Biocon Limited (Standalone) Profit & Loss Statement

    BIOCON LIMITED (STANDALONE) PROFIT & LOSS STATEMENT (Rs. crores) Variance Variance Full Year Q2 Q2 Q2 FY 05 H1 H1 H1 FY 05 ended Particulars vs vs March 31, FY 2005 FY 2004 Q2 FY 04 FY 2005 FY 2004 H1 FY 04 2004 INCOME Sales 171 140 21% 331 240 38% 502 Contract research fees 0 0 0 0 1 Other income 3

  6. Slide 6: Syngene International Private Limited (Standalone) Profit & Loss Statement

    SYNGENE INTERNATIONAL PRIVATE LIMITED (STANDALONE) PROFIT & LOSS STATEMENT (Rs. crores) Variance Variance Full Year Q2 Q2 Q2 FY 05 H1 H1 H1 FY 05 ended Particulars vs vs March 31, FY 2005 FY 2004 Q2 FY 04 FY 2005 FY 2004 H1 FY 04 2004 INCOME Contract research fees 13 7 96% 25 14 81% 32 Sale of compo

  7. Slide 7: Clinigene International Private Limited (Standalone) Profit & Loss Statement

    CLINIGENE INTERNATIONAL PRIVATE LIMITED (STANDALONE) PROFIT & LOSS STATEMENT (Rs. crores) Variance Variance Full Year Q2 Q2 Q2 FY 05 H1 H1 H1 FY 05 ended Particulars vs vs March 31, FY 2005 FY 2004 Q2 FY 04 FY 2005 FY 2004 H1 FY 04 2004 INCOME Contract research fees 0 0 0 0 1 Other income 0 0 0 0 0

Biocon — Q2 FY2005 Earnings Presentation on 6ix